The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study

Journal of Affective Disorders

Volumn 235, Issue , 2018, Pages 506-512

  Kurokawa, Shunya ^a   Kishimoto, Taishiro ^a   Mizuno, Shinta ^a   Masaoka, Tatsuhiro ^a   Naganuma, Makoto ^a   Liang, Kuo ching ^a   Kitazawa, Momoko ^a   Nakashima, Moeko ^a   Shindo, Chie ^c,d   Suda, Wataru ^b,c   Hattori, Masahira ^c,d   Kanai, Takanori ^a   Mimura, Masaru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d WASEDA UNIVERSITY   (Japan)

Author keywords

Anxiety; Depression; Fecal microbiota transplant; Functional gastrointestinal disorders; Irritable bowel syndrome; Microbiome

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ANXIETY ASSESSMENT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; EUBACTERIUM; EUBACTERIUM RECTALE; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FOLLOW UP; FUNCTIONAL CONSTIPATION; FUNCTIONAL DIARRHEA; GASTROINTESTINAL SYMPTOM; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MALE; MENTAL DISEASE; MICROBIAL DIVERSITY; MICROBIOME; OBSERVATIONAL STUDY; OPEN STUDY; PRIORITY JOURNAL; STREPTOCOCCUS SALIVARIUS; ANXIETY DISORDER; DEPRESSION; FECES; GASTROINTESTINAL DISEASE; MICROBIOLOGY; MIDDLE AGED; PSYCHOLOGY;

ADULT; ANXIETY DISORDERS; CONSTIPATION; DEPRESSIVE DISORDER; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED;

EID: 85045722580     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2018.04.038     Document Type: Article

References (44)

1. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M.R., Asemi, Z., Esmaillzadeh, A., Reza, M., Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32 (2016), 315–320.
2. Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., Young, V.B., Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 3 (2008), 435–438.
3. Cockburn, D.W., Suh, C., Medina, K.P., Duvall, R.M., Wawrzak, Z., Henrissat, B., Koropatkin, N.M., Novel carbohydrate binding modules in the surface anchored α-amylase of Eubacterium rectale provide a molecular rationale for the range of starches used by this organism in the human gut. Mol. Microbiol. 2 (2018), 249–264.
4. Evans, S.J., Bassis, C.M., Hein, R., Assari, S., Flowers, S.A., Kelly, M.B., Young, V.B., Ellingrod, V.E., McInnis, M.G., The gut microbiome composition associates with bipolar disorder and illness severity. J. Psychiatr. Res. 87 (2017), 23–29.
5. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
6. Gossling, J., Slack, J.M., Predominant gram-positive bacteria in human feces: numbers, variety, and persistence. Infect. Immun. 9 (1974), 719–729.
7. Halkjaer, S.I., Watt Boolsen, A., Günther, S., Christensen, A.H., Munk, A., Sofie, P., Halkjaer, I., Petersen, A.M., Can fecal microbiota transplantation cure irritable bowel syndrome?. World J. Gastroenterol. 23 (2017), 4112–4120.
8. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., Li, L., Ruan, B., Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48 (2015), 186–194.
9. Kang, D.-W., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., Pollard, E.L., Roux, S., Sadowsky, M.J., Lipson, K.S., Sullivan, M.B., Caporaso, J.G., Krajmalnik-Brown, R., Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome, 5, 2017, 10.
10. Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Irritable bowel syndrome: a microbiome-gut-brain axis disorder?. World J. Gastroenterol. 20 (2014), 14105–14125.
11. Knip, M., Honkanen, J., Modulation of type 1 diabetes risk by the intestinal microbiome. Curr. Diabetes Rep., 17, 2017, 105.
12. Kootte, R.S., Levin, E., Salojärvi, J., Smits, L.P., Hartstra, A.V., Udayappan, S.D., Hermes, G., Bouter, K.E., Koopen, A.M., Holst, J.J., Knop, F.K., Blaak, E.E., Zhao, J., Smidt, H., Harms, A.C., Hankemeijer, T., Bergman, J.J.G.H.M., Romijn, H.A., Schaap, F.G., Olde Damink, S.W.M., Ackermans, M.T., Dallinga-Thie, G.M., Zoetendal, E., de Vos, W.M., Serlie, M.J., Stroes, E.S.G., Groen, A.K., Nieuwdorp, M., Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 26 (2017), 611–619 e6.
13. Kriston, L., Wolff, A.Von, Not as golden as standards should be: Interpretation of the Hamilton Rating Scale for Depression. J. Affect. Disord. 128 (2011), 175–177.
14. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jørgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., Zoetendal, E.G., Brunak, S., Clément, K., Doré, J., Kleerebezem, M., Kristiansen, K., Renault, P., Sicheritz-Ponten, T., De Vos, W.M., Zucker, J.D., Raes, J., Hansen, T., Bork, P., Wang, J., Ehrlich, S.D., Pedersen, O., Guedon, E., Delorme, C., Layec, S., Khaci, G., Van De Guchte, M., Vandemeulebrouck, G., Jamet, A., Dervyn, R., Sanchez, N., Maguin, E., Haimet, F., Winogradski, Y., Cultrone, A., Leclerc, M., Juste, C., Blottière, H., Pelletier, E., Lepaslier, D., Artiguenave, F., Bruls, T., Weissenbach, J., Turner, K., Parkhill, J., Antolin, M., Manichanh, C., Casellas, F., Boruel, N., Varela, E., Torrejon, A., Guarner, F., Denariaz, G., Derrien, M., Van Hylckama Vlieg, J.E.T., Veiga, P., Oozeer, R., Knol, J., Rescigno, M., Brechot, C., M'Rini, C., Mérieux, A., Yamada, T., Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
15. Lee, Y.-T., Hu, L.-Y., Shen, C.-C., Huang, M.-W., Tsai, S.-J., Yang, A.C., Hu, C.-K., Perng, C.-L., Huang, Y.-S., Hung, J.-H., Risk of psychiatric disorders following irritable bowel syndrome: a nationwide population-based cohort study. PLoS One, 10, 2015, e0133283.
16. Leonel, A.J., Alvarez-Leite, J.I., Butyrate: implications for intestinal function. Curr. Opin. Clin. Nutr. Metab. Care 15 (2012), 474–479.
17. Leslie, D.L., Kozma, L., Martin, A., Landeros, A., Katsovich, L., King, R.A., Leckman, J.F., Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J. Am. Acad. Child Adolesc. Psychiatry 47 (2008), 1166–1172.
18. Lewis, S.J., Heaton, K.W., Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 32 (1997), 920–924.
19. Lin, P., Ding, B., Feng, C., Yin, S., Zhang, T., Qi, X., Lv, H., Guo, X., Dong, K., Zhu, Y., Li, Q., Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J. Affect. Disord. 207 (2017), 300–304.
20. Liu, Y., Zhang, L., Wang, X.X., Wang, Z., Zhang, J., Jiang, R., Wang, X.X., Wang, K., Liu, Z., Xia, Z., Xu, Z., Nie, Y., Lv, X., Wu, X., Zhu, H., Duan, L., Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin. Gastroenterol. Hepatol. 14 (2016), 1602–1611 e5.
21. Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F., Spiller, R.C., Functional bowel disorders. Gastroenterology 130 (2006), 1480–1491.
22. Lovell, R.M., Ford, A.C., Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin. Gastroenterol. Hepatol. 10 (2012), 712–721.
23. Matsuoka, K., Mizuno, S., Hayashi, A., Hisamatsu, T., Naganuma, M., Kanai, T., Fecal microbiota transplantation for gastrointestinal diseases. Keio J. Med. 63 (2014), 69–74.
24. Matza, L.S., Morlock, R., Sexton, C., Malley, K., Feltner, D., Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int. J. Methods Psychiatr. Res. 19 (2010), 223–232.
25. Mayer, E.A., Savidge, T., Shulman, R.J., Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146 (2014), 1500–1512.
26. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.F., Rougeot, C., Pichelin, M., Cazaubiel, M., Cazaubiel, J.M., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 in rats and human subjects. Br. J. Nutr. 105 (2011), 755–764.
27. Mizuno, S., Masaoka, T., Naganuma, M., Kishimoto, T., Kitazawa, M., Kurokawa, S., Nakashima, M., Takeshita, K., Suda, W., Mimura, M., Hattori, M., Kanai, T., Bifidobacterium -rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome. Digestion 96 (2017), 29–38.
28. Moayyedi, P., Surette, M.G., Kim, P.T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J.K., Kassam, Z., Reinisch, W., Lee, C.H., Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 149 (2015), 102–109.
29. Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V, Reyes, J.A., Shah, S.A., LeLeiko, N., Snapper, S.B., Bousvaros, A., Korzenik, J., Sands, B.E., Xavier, R.J., Huttenhower, C., Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol., 13, 2012, R79.
30. Moussavi, S, Chatterji, S, Verdes, E, Tandon, A, Patel, V, B., U., Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370 (2007), 851–858.
31. Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., Rudi, K., Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 26 (2014), 1155–1162.
32. Pinto-Sanchez, M.I., Ford, A.C., Avila, C.A., Verdu, E.F., Collins, S.M., Morgan, D., Moayyedi, P., Bercik, P., Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am. J. Gastroenterol. 110 (2015), 1038–1048.
33. Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J.T., Martin, F.-P., Cominetti, O., Welsh, C., Rieder, A., Traynor, J., Gregory, C., De Palma, G., Pigrau, M., Ford, A.C., Macri, J., Berger, B., Bergonzelli, G., Surette, M.G., Collins, S.M., Moayyedi, P., Bercik, P., Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153 (2017), 448–459.
34. Pozuelo, M., Panda, S., Santiago, A., Mendez, S., Accarino, A., Santos, J., Guarner, F., Azpiroz, F., Manichanh, C., Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci. Rep., 5, 2015, 12693.
35. Rossen, N.G., MacDonald, J.K., De Vries, E.M., D'Haens, G.R., De Vos, W.M., Zoetendal, E.G., Ponsioen, C.Y., Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J. Gastroenterol. 21 (2015), 5359–5371.
36. Sibelli, A., Chalder, T., Everitt, H., Workman, P., Windgassen, S., Moss-Morris, R., A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol. Med. 46 (2016), 3065–3080.
37. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.-N., Kubo, C., Koga, Y., Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. J. Physiol 558 (2004), 263–275.
38. Tian, H., Ding, C., Gong, J., Ge, X., McFarland, L.V., Gu, L., Wei, Y., Chen, Q., Zhu, W., Li, J., Li, N., Treatment of slow transit constipation with fecal microbiota transplantation. J. Clin. Gastroenterol. 50 (2016), 865–870.
39. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R., Gordon, J.I., A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
40. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F.W.M., Tijssen, J.G.P., Speelman, P., Dijkgraaf, M.G.W., Keller, J.J., Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
41. Vaughn, B.P., Vatanen, T., Allegretti, J.R., Bai, A., Xavier, R.J., Korzenik, J., Gevers, D., Ting, A., Robson, S.C., Moss, A.C., Increased intestinal microbial diversity following fecal microbiota transplant for active Crohnʼs disease. Inflammatory Bowel Dis. 22 (2016), 2182–2190.
42. Wei, Y., Zhu, W., Gong, J., Guo, D., Gu, L., Li, N., Li, J., Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease. Gastroenterol. Res. Pract., 2015, 517597.
43. Xu, D., Gao, J., Gillilland, M. III, Wu, X., Song, I., Kao, J.Y., Owyang, C., Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology 146 (2014), 484–496 e4.
44. Yang, Y., Tian, J., Yang, B., Targeting gut microbiome: a novel and potential therapy for autism. Life Sci. 194 (2018), 111–119.